Sunshine Biopharma (SBFMW) Capital Expenditures Growth (1y) (2016 - 2026)
Sunshine Biopharma (SBFMW) Capital Expenditures Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 32.28% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 3,566.67% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 113.56% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -14.95% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -21.54% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -59.55% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -76.65% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 4,261.59% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -31.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.52% |
| Dec 31, 2025 | -101.01% |
| Sep 30, 2025 | -98.44% |
| Jun 30, 2025 | -83.58% |
| Mar 31, 2025 | -88.10% |
| Dec 31, 2024 | 126.83% |
| Sep 30, 2024 | 5,266.46% |
| Dec 31, 2023 | -297.11% |
| Dec 31, 2020 | -54.53% |
| Sep 30, 2020 | 264.95% |
| Dec 31, 2019 | 110.09% |
| Sep 30, 2019 | -109.70% |
| Jun 30, 2019 | -97.24% |
| Dec 31, 2018 | -329.16% |
| Sep 30, 2018 | 122.43% |
| Jun 30, 2018 | -21.12% |
| Dec 31, 2017 | 239.23% |
| Jun 30, 2017 | 851.56% |
| Dec 31, 2016 | -77.13% |